PT  - JOURNAL ARTICLE
AU  - Takashi Nakano
AU  - Yoichi Ikeda
TI  - Novel indicator of change in COVID-19 spread status
AID  - 10.1101/2020.04.25.20080200
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.25.20080200
4099  - http://medrxiv.org/content/early/2020/05/05/2020.04.25.20080200.short
4100  - http://medrxiv.org/content/early/2020/05/05/2020.04.25.20080200.full
AB  - In the fight against the pandemic of COVID-19, it is important to be quick to detect changes in the rate of spread and to be precise to predict the future. We have succeeded in formulating a new indicator based on daily number of infected people from publicly available data, which enables us to do the both. We show the validity of the indicator by demonstrating that a universal analysis of current status of COVID-19 spreading over countries can predict effects of measures such as the blockage of cities and social distancing, signs of new spread, and possible regional dependence in the formation of herd immunity.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe collected data from publicly available data sources: https://ourworldindata.org/coronavirus-source-data https://web.sapmed.ac.jp/canmol/coronavirus/index.html The COVID Tracking Project, https://covidtracking.com/data/us-daily NIPPON TELEVISION NETWORK CORPORATION, COVID-19 special site. https://www.news24.jp/archives/corona_map/index2.html